Leprosy. A preliminary review of the experimental evaluation of drugs for the treatment of leprosy.
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents / Q000627:therapeutic use; D003523:Cycloserine / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D009166:Mycobacterium leprae / Q000187:drug effects; D010619:Phenazines / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D010619:Phenazines; D013440:Sulfides; D011718:Pyrazinamide; D013412:Sulfadimethoxine; D004977:Ethambutol; D014508:Urea; D003523:Cycloserine; D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin